Reduced Telomere Length in Colorectal Carcinomas

  • Feng, Tong-Bao (Department of Oncology, the Affiliated Hospital of Nanjing Medical University) ;
  • Cai, Lei-Ming (Department of Pathology, the Affiliated Hospital of Nanjing Medical University) ;
  • Qian, Ke-Qing (Department of Oncology, the Affiliated Hospital of Nanjing Medical University) ;
  • Qi, Chun-Jian (Department of Oncology, the Affiliated Hospital of Nanjing Medical University)
  • Published : 2012.02.29


Purpose: Telomeres play a key role in the maintenance of chromosome integrity and stability, and telomere shortening is involved in initiation and progression of malignancies. The aim of this study was to determine whether telomere length is associated with the colorectal carcinoma. Patients and methods: A total of 148 colorectal cancer (CRC) samples and corresponding adjacent non-cancerous tissues were evaluated for telomere length, P53 mutation, and cyclooxygenase-2 (COX-2) mutation detected by fluorescent immunohistochemistry. Telomere length was estimated by real-time PCR. Samples with a T/S>1.0 have an average telomere length greater than that of the standard DNA; samples with a T/S<1.0 have an average telomere length shorter than that of the standard DNA. Results: Telomeres were shorter in CRCs than in adjacent tissues, regardless of tumor stage and grade, site, or genetic alterations (P=0.004). Telomere length in CRCs also had differences with COX-2 status (P=0.004), but did not differ with P53 status (P=0.101), tumor progression (P=0.244), gender (P=0.542), and metastasis (P=0.488). There was no clear trend between T/S optimal cut-off values (<1 or > 1) and colorectal tumor progression, metastasis, gender, P53 and COX-2 status. Conclusion: These findings suggesting that telomere shortening is associated with colorectal carcinogenesis but does not differ with tumor progression, gender, and metastasis.


Telomere length;colorectal cancer;COX-2;China


  1. Aviv A, Valdes A, Gardner JP, et al (2006). Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab, 91, 635-40.
  2. Broberg K, Bjork J, Paulsson K, et al (2005). Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis, 26, 1263-71.
  3. Brouilette SW, Moore JS, McMahon AD, et al (2007). Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet, 369, 107-14.
  4. Cawthon RM (2002). Telomere measurement by quantitative PCR. Nucleic Acids Res, 30, e47.
  5. Cawthon RM (2009). Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res, 37, e21.
  6. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al (2003).A DNA damage checkpoint response in telomere-initiated senescence. Nature, 426, 194-8.
  7. Demissie S, Levy D, Benjamin EJ, et al (2006). Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell, 5, 325-30.
  8. Engelhardt M, Drullinsky P, Guillem J, et al (1997). Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res, 3, 1931-41.
  9. Fitzpatrick AL, Kronmal RA, Gardner JP, et al (2007). Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol, 165,14-21.
  10. Garcia-Aranda C, de Juan C, Diaz-Lopez A, et al (2006). Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma. Cancer, 106, 541-51.
  11. Gertler R, Rosenberg R, Stricker D, et al (2004). Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol, 22, 1807-14.
  12. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 434, 907-13.
  13. Greider CW, Blackburn EH (1989). A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature, 337, 331-7.
  14. Kim HR, Kim YJ, Kim HJ, et al (2002).Telomere length changes in colorectal cancers and polyps. J Korean Med Sci, 17, 360-5.
  15. Kim S, Sandler DP, Carswell G, et al (2011). Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study. Cancer Causes Control, 22, 1061-6.
  16. McGrath M, Wong JY, Michaud D, et al (2007). Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev, 16, 815-9.
  17. Meeker AK, Hicks JL, Gabrielson E, et al (2004). Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol, 164, 925-35.
  18. Nakamura K, Furugori E, Esaki Y, et al (2000). Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett, 158, 179-84.
  19. O'Callaghan N, Dhillon V, Thomas P, Fenech M (2008). A quantitative real-time PCR method for absolute telomere length. Biotechniques, 44, 807-9.
  20. O'Sullivan J, Risques RA, Mandelson MT, et al (2006). Telomere length in the colon declines with age: a relation to colorectal cancer? Cancer Epidemiol Biomarkers Prev, 15, 573-7.
  21. Prescott J, McGrath M, Lee IM, et al (2010). Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer, 116, 4275-82.
  22. Raynaud CM, Jang SJ, Nuciforo P, et al (2008). Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions. Ann Oncol 2008, 19, 1875-81.
  23. Verdun RE, Karlseder J (2007). Replication and protection of telomeres. Nature, 447, 924-31.
  24. von Zglinicki T (2002). Oxidative stress shortens telomeres. Trends Biochem Sci, 27, 339-44.
  25. Wu X, Amos CI, Zhu Y, et al (2003). Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003, 95, 1211-8.

Cited by

  1. 3R Variant of Thymidylate Synthase 5'-untranslated Enhanced Region Contributes to Colorectal Cancer Risk: A Meta-analysis vol.13, pp.6, 2012,
  2. The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma vol.58, pp.4, 2016,